Abstract

Tumor heterogeneity and differential drug response in 3D tissue is a major obstacle for survival of cancer patients. Biodynamic 3D imaging provides personalized therapy assessment by testing heterogeneous response of tumor biopsies to anti-cancer drugs.

© 2014 OSA

PDF Article | Presentation Video

Supplementary Material (1)

Presentation video access is available to:

  1. OSA Publishing subscribers
  2. Technical meeting attendees
  3. OSA members who wish to use one of their free downloads. Please download the article first. After downloading, please refresh this page.

Contact your librarian or system administrator
or
Log in to access OSA Member Subscription or free downloads